ID   GG
AC   CVCL_A1IB
DR   Wikidata; Q102113870
RX   DOI=10.5282/edoc.3898;
RX   PubMed=9384677;
RX   PubMed=10359208;
RX   PubMed=12836015;
RX   PubMed=15706405;
CC   HLA typing: A*02,32; B*07,27; C*01,07; DQA1*04:01,05:01; DQB1*03:01,04; DRB1*08,11 (PubMed=10359208).
CC   HLA typing: A*02,32; B*07,27; DQB1*03,04:02; DRB1*08:01,11:03 (PubMed=12836015).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
RX   DOI=10.5282/edoc.3898;
RA   Euer N.I.;
RT   "Identification of target genes for the therapy and diagnosis of
RT   ovarian carcinoma.";
RL   Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany.
//
RX   PubMed=9384677;
RA   Guckel B., Lindauer M., Rudy W., Habicht A., Siebels M., Kaul S.,
RA   Bastert G., Meuer S.C., Moebius U.;
RT   "CD80-transfected human breast and ovarian tumor cell lines: improved
RT   immunogenicity and induction of cytolytic CD8+ T lymphocytes.";
RL   Cytokines Mol. Ther. 1:211-221(1995).
//
RX   PubMed=10359208; DOI=10.1038/sj.cgt.7700050;
RA   Guckel B., Meyer G.C., Rudy W., Batrla R., Meuer S.C., Bastert G.,
RA   Wallwiener D., Moebius U.;
RT   "Interleukin-12 requires initial CD80-mediated T-cell activation to
RT   support immune responses toward human breast and ovarian carcinoma.";
RL   Cancer Gene Ther. 6:228-237(1999).
//
RX   PubMed=12836015; DOI=10.1007/s00432-003-0445-7;
RA   Kayser S., Watermann I., Rentzsch C., Weinschenk T., Wallwiener D.,
RA   Guckel B.;
RT   "Tumor-associated antigen profiling in breast and ovarian cancer:
RT   mRNA, protein or T cell recognition?";
RL   J. Cancer Res. Clin. Oncol. 129:397-409(2003).
//
RX   PubMed=15706405; DOI=10.3892/or.13.3.375;
RA   Euer N.I., Kaul S., Deissler H., Mobus V.J., Zeillinger R.,
RA   Weidle U.H.;
RT   "Identification of L1CAM, Jagged2 and neuromedin U as ovarian
RT   cancer-associated antigens.";
RL   Oncol. Rep. 13:375-387(2005).
//